Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Integrin receptor-binding nanofibrous peptide hydrogel for combined mesenchymal stem cell therapy and nitric oxide delivery in renal ischemia/reperfusion injury

Fig. 3

WJ-MSC viability in various concentrations of Fmoc-FF, either in combination with Fmoc-RGD, Fmoc-RGE, or alone (A) and after encapsulation in the 3D hydrogel scaffold for different incubation times (B). a, b, c, d, e, and f: inter-group comparisons according to the Tukey follow-up test; groups with the same superscripts were not significantly different at α = 0.05 (P > 0.05); however, dissimilar letters indicate a significant difference (P < 0.05)

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512